PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BGB-45035 enters first human trials for skin conditions
Disease control Recruiting nowThis early-stage study tests a new drug called BGB-45035 for safety and how the body processes it. First, healthy volunteers receive single or multiple doses. Then, people with autoimmune skin diseases like atopic dermatitis (eczema) or prurigo nodularis receive the drug to check…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 17, 2026 05:25 UTC
-
New hope for kids with brutal itch: dupilumab trial launches
Symptom relief Recruiting nowThis study tests a drug called dupilumab in 18 children and teens (6 months to under 18 years) with prurigo nodularis, a skin condition causing very itchy bumps. The main goal is to see how the drug moves through the body and if it is safe. Participants receive the drug for 24 we…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 17, 2026 05:25 UTC
-
New shot could scratch the itch for nodularis sufferers
Symptom relief Recruiting nowThis study tests an investigational drug called SHR-1819 in 423 adults with prurigo nodularis, a skin condition causing intense, persistent itching. Participants receive either the drug or a placebo injection, and researchers measure how much itching improves over 16-24 weeks. Th…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 17, 2026 05:09 UTC
-
New real-world study to see if nemolizumab tames stubborn itch and skin bumps
Symptom relief Recruiting nowThis study is testing how well nemolizumab works for adults with moderate-to-severe prurigo nodularis, a skin condition causing intense itching and bumpy lesions. Researchers will track 600 participants over 6 to 12 months in real-world clinics, measuring itch severity and skin c…
Matched conditions: PRURIGO NODULARIS
Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 17, 2026 05:04 UTC
-
New pill aims to stop the itch-scratch cycle in prurigo nodularis
Symptom relief Recruiting nowThis study tests an experimental drug called povorcitinib in 330 adults with prurigo nodularis, a condition causing intense itching and many skin bumps. The goal is to see if the drug reduces itch and clears lesions better than a placebo over 24 weeks. Participants must have had …
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC